JPRN-UMIN000004929已完成1 期
A clinical study of adenovirus mediated Reduced Expression in Immortalized Cells/Dickkopf-3(REIC/Dkk-3)gene therapy for prostate cancer - Prostate cancer gene therapy using REIC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1 Uncontrolled infectious disease 2 Patient who received clinical trial 3 Concomitant malingant disese. Interval of NED is exceptional 4 Patient who had a histor of withdrawal from this trial 5 Patient who are considered by investigator as unappropriate for this trial
研究者
相似试验
已完成
1 期
A clinical study of adenovirus mediated Reduced Expression in Immortalized Cells/Dickkopf-3 (REIC/Dkk-3) gene therapy for malignant pleural mesotheliomamalignant pleural mesotheliomaJPRN-UMIN000013568Okayama University Hospital24
已完成
1 期
Treatment of neuroendocrine neoplasms with genetically modified adenovirus2024-517654-10-00Uppsala University20
尚未招募
不适用
Research on the evaluation of adenovirus antigen detection kitepidemic keratoconjunctivitisJPRN-UMIN000027952Fukuoka University50
进行中（未招募）
1 期
Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and EfficacyNeuroendocrine TumorsNCT02749331Uppsala University35
已完成
不适用
Oncolytic adenovirus therapy as an adjuvant treatment for localised prostate cancer.Prostate carcinoma1003859710036958prostate cancerNL-OMON43563Erasmus MC, Universitair Medisch Centrum Rotterdam18